{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:31:39Z","timestamp":1794537099511,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T00:00:00Z","timestamp":1653177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T00:00:00Z","timestamp":1653177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hallym University Research Fund"},{"name":"National Research Foundation of Korea (NRF) grant funded by the Korean government","award":["2021R1I1A3051083"],"award-info":[{"award-number":["2021R1I1A3051083"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The atherogenic index of plasma (AIP) is composed of triglycerides and high-density lipoprotein cholesterol and is a novel marker for assessing the risk of atherogenicity and cardiometabolic health. An association between AIP and greater frequency of major adverse cardiovascular events (MACEs) in patients with type 2 diabetes mellitus and high cardiovascular (CV) disease risk has been reported. However, only few studies have examined the correlation between AIP and CV risk in general populations. We thus aimed to evaluate the relationship between AIP and CV diseases using a large-scale population dataset from the Korean National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 514,866 participants were enrolled from the NHIS-HEALS and classified according to the AIP quartiles. We performed univariate and multivariate Cox proportional hazards regression analyses to determine the association between AIP and MACEs, CV events, and CV mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During follow-up, we documented 12,133, 11,055, and 1942 cases of MACEs, CV events, and CV mortality, respectively. The multivariate-adjusted hazard ratios [HRs; 95% confidence interval (CI)] for MACEs gradually and significantly increased with the AIP quartiles [1.113 (1.054\u20131.175) in Q2, 1.175 (1.113\u20131.240) in Q3, and 1.278 (1.209\u20131.350) in Q4], following an adjustment for the conventional CV risk factors, including age, sex, body mass index, smoking, alcohol drinking, physical activities, household income, fasting glucose, systolic blood pressure, low-density lipoprotein cholesterol, and estimated glomerular filtration rate. In subgroup analyses, the association of AIP with MACEs and CV events was particularly outstanding in patients with diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AIP was significantly associated with CV risks after adjusting for the traditional risk factors. Therefore, it may be used as an effective mass screening method to identify patients at a high risk of CV events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-022-01522-8","type":"journal-article","created":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T04:02:34Z","timestamp":1653192154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":182,"title":["Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Si Hyoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Kyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Jee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Je","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong-Yeol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hye","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Goo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hee","family":"Ihm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,22]]},"reference":[{"key":"1522_CR1","doi-asserted-by":"crossref","unstructured":"Correction. J Am Coll Cardiol 2021; 77(15): 1958\u20131959.","DOI":"10.1016\/j.jacc.2021.02.039"},{"issue":"12","key":"1522_CR2","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/CIRCRESAHA.119.310859","volume":"125","author":"JI Shin","year":"2019","unstructured":"Shin JI, Oh J, Kim HC, Choi D, Yoon YS. Current State of Cardiovascular Research in Korea. Circ Res. 2019;125(12):1141\u20135.","journal-title":"Circ Res"},{"issue":"Suppl 2","key":"1522_CR3","first-page":"S158-S167","volume":"31","author":"J Yoon","year":"2016","unstructured":"Yoon J, Seo H, Oh IH, Yoon SJ. The Non-Communicable Disease Burden in Korea: Findings from the 2012 Korean Burden of Disease Study. J Korean Med Sci. 2016;31(Suppl 2):S158\u201367.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"1522_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1172\/JCI62876","volume":"123","author":"D Quiat","year":"2013","unstructured":"Quiat D, Olson EN. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest. 2013;123(1):11\u20138.","journal-title":"J Clin Invest"},{"issue":"4","key":"1522_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7570\/jomes.2019.28.4.262","volume":"28","author":"HY Kim","year":"2019","unstructured":"Kim HY, Kim JK, Shin GG, Han JA, Kim JW. Association between abdominal obesity and cardiovascular risk factors in adults with normal body mass index: based on the sixth korea national health and nutrition examination survey. J Obes Metab Syndr. 2019;28(4):262\u201370.","journal-title":"J Obes Metab Syndr"},{"issue":"29","key":"1522_CR6","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315\u201381.","journal-title":"Eur Heart J"},{"issue":"4","key":"1522_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4093\/dmj.2019.0137","volume":"43","author":"MK Kim","year":"2019","unstructured":"Kim MK, Ko SH, Kim BY, Kang ES, Noh J, Kim SK, Park SO, Hur KY, Chon S, Moon MK, et al. 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea. Diabetes Metab J. 2019;43(4):398\u2013406.","journal-title":"Diabetes Metab J"},{"issue":"11","key":"1522_CR8","first-page":"e596-e646","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, et al. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596\u2013646.","journal-title":"Circulation"},{"key":"1522_CR9","first-page":"240","volume":"29","author":"S Niroumand","year":"2015","unstructured":"Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, Dadgarmoghaddam M. Atherogenic Index of Plasma (AIP): A marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29:240.","journal-title":"Med J Islam Repub Iran"},{"issue":"3","key":"1522_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","volume":"4","author":"AD Sniderman","year":"2011","unstructured":"Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, de Graaf J, Furberg CD. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011;4(3):337\u201345.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"20","key":"1522_CR11","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa021993","volume":"347","author":"PM Ridker","year":"2002","unstructured":"Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557\u201365.","journal-title":"N Engl J Med"},{"issue":"10","key":"1522_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.5603\/KP.a2015.0086","volume":"73","author":"L Zhu","year":"2015","unstructured":"Zhu L, Lu Z, Zhu L, Ouyang X, Yang Y, He W, Feng Y, Yi F, Song Y. Lipoprotein ratios are better than conventional lipid parameters in predicting coronary heart disease in Chinese Han people. Kardiol Pol. 2015;73(10):931\u20138.","journal-title":"Kardiol Pol"},{"issue":"7","key":"1522_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","volume":"34","author":"M Dobiasova","year":"2001","unstructured":"Dobiasova M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583\u20138.","journal-title":"Clin Biochem"},{"issue":"1","key":"1522_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2015.06.057","volume":"242","author":"R Quispe","year":"2015","unstructured":"Quispe R, Manalac RJ, Faridi KF, Blaha MJ, Toth PP, Kulkarni KR, Nasir K, Virani SS, Banach M, Blumenthal RS, et al. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG\/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study. Atherosclerosis. 2015;242(1):243\u201350.","journal-title":"Atherosclerosis"},{"issue":"3","key":"1522_CR15","first-page":"248","volume":"10","author":"UI Nwagha","year":"2010","unstructured":"Nwagha UI, Ikekpeazu EJ, Ejezie FE, Neboh EE, Maduka IC. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. Afr Health Sci. 2010;10(3):248\u201352.","journal-title":"Afr Health Sci"},{"issue":"1","key":"1522_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12933-021-01393-5","volume":"20","author":"L Fu","year":"2021","unstructured":"Fu L, Zhou Y, Sun J, Zhu Z, Xing Z, Zhou S, Wang Y, Tai S. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):201.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"1522_CR17","doi-asserted-by":"publisher","first-page":"e016640","DOI":"10.1136\/bmjopen-2017-016640","volume":"7","author":"SC Seong","year":"2017","unstructured":"Seong SC, Kim YY, Park SK, Khang YH, Kim HC, Park JH, Kang HJ, Do CH, Song JS, Lee EJ, et al. Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ Open. 2017;7(9):e016640.","journal-title":"BMJ Open"},{"issue":"1","key":"1522_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-020-0989-8","volume":"19","author":"Z Qin","year":"2020","unstructured":"Qin Z, Zhou K, Li Y, Cheng W, Wang Z, Wang J, Gao F, Yang L, Xu Y, Wu Y, et al. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):23.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1522_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.advms.2021.09.003","volume":"66","author":"M Sadeghi","year":"2021","unstructured":"Sadeghi M, Heshmat-Ghahdarijani K, Talaei M, Safaei A, Sarrafzadegan N, Roohafza H. The predictive value of atherogenic index of plasma in the prediction of cardiovascular events; a fifteen-year cohort study. Adv Med Sci. 2021;66(2):418\u201323.","journal-title":"Adv Med Sci"},{"issue":"Suppl 3","key":"1522_CR20","first-page":"C10-13","volume":"22","author":"JD Brunzell","year":"1999","unstructured":"Brunzell JD, Hokanson JE. Dyslipidemia of central obesity and insulin resistance. Diabetes Care. 1999;22(Suppl 3):C10-13.","journal-title":"Diabetes Care"},{"issue":"1","key":"1522_CR21","first-page":"64","volume":"52","author":"M Dobiasova","year":"2006","unstructured":"Dobiasova M. [AIP\u2013atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice]. Vnitr Lek. 2006;52(1):64\u201371.","journal-title":"Vnitr Lek"},{"issue":"4","key":"1522_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4103\/0972-2327.120438","volume":"16","author":"MC Cure","year":"2013","unstructured":"Cure MC, Tufekci A, Cure E, Kirbas S, Ogullar S, Kirbas A, Unal H, Yuce S, Cakmak S. Low-density lipoprotein subfraction, carotid artery intima-media thickness, nitric oxide, and tumor necrosis factor alpha are associated with newly diagnosed ischemic stroke. Ann Indian Acad Neurol. 2013;16(4):498\u2013503.","journal-title":"Ann Indian Acad Neurol"},{"key":"1522_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-016-0229-0","volume":"15","author":"K Gaal","year":"2016","unstructured":"Gaal K, Tarr T, Lorincz H, Borbas V, Seres I, Harangi M, Fulop P, Paragh G. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus. Lipids Health Dis. 2016;15:60.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"1522_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/hdi.12041","volume":"17","author":"G Yildiz","year":"2013","unstructured":"Yildiz G, Duman A, Aydin H, Yilmaz A, Hur E, Magden K, Cetin G, Candan F. Evaluation of association between atherogenic index of plasma and intima-media thickness of the carotid artery for subclinic atherosclerosis in patients on maintenance hemodialysis. Hemodial Int. 2013;17(3):397\u2013405.","journal-title":"Hemodial Int"},{"key":"1522_CR25","doi-asserted-by":"crossref","unstructured":"Nam JS, Kim MK, Park K, Choi A, Kang S, Ahn CW, Park JS: The Plasma Atherogenic Index is an Independent Predictor of Arterial Stiffness in Healthy Koreans. Angiology 2021:33197211054242.","DOI":"10.1177\/00033197211054242"},{"key":"1522_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2021.03.009","volume":"324","author":"KB Won","year":"2021","unstructured":"Won KB, Heo R, Park HB, Lee BK, Lin FY, Hadamitzky M, Kim YJ, Sung JM, Conte E, Andreini D, et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis. 2021;324:46\u201351.","journal-title":"Atherosclerosis"},{"key":"1522_CR27","doi-asserted-by":"crossref","unstructured":"Kim JJ, Yoon J, Lee YJ, Park B, Jung DH. Predictive Value of the Atherogenic Index of Plasma (AIP) for the Risk of Incident Ischemic Heart Disease among Non-Diabetic Koreans. Nutrients.\u00a02021;\u00a013(9): 3231","DOI":"10.3390\/nu13093231"},{"key":"1522_CR28","doi-asserted-by":"publisher","first-page":"108497","DOI":"10.1016\/j.diabres.2020.108497","volume":"170","author":"TV Varga","year":"2020","unstructured":"Varga TV, Niss K, Estampador AC, Collin CB, Moseley PL. Association is not prediction: a landscape of confused reporting in diabetes - a systematic review. Diabetes Res Clin Pract. 2020;170:108497.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"1522_CR29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jamapsychiatry.2019.3671","volume":"77","author":"RA Poldrack","year":"2020","unstructured":"Poldrack RA, Huckins G, Varoquaux G. Establishment of best practices for evidence for prediction: a review. JAMA Psychiatry. 2020;77(5):534\u201340.","journal-title":"JAMA Psychiatry"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01522-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01522-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01522-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T04:02:58Z","timestamp":1653192178000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01522-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,22]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1522"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01522-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,22]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Hallym University, Republic of Korea (HALLYM 2021-05-007). Anonymous and de-identified information was used for analysis; therefore, informed consent was not obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}